Cargando…
Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response
Pneumonic plague is a lethal infectious disease caused by Yersinia pestis, a Tier-1 biothreat agent. Antibiotic treatment can save infected patients; however, therapy should begin within 24 h of symptom onset. As some Y. pestis strains showed an antibiotic resistance phenotype, an antibiotic suscept...
Autores principales: | Moses, Sarit, Aftalion, Moshe, Mamroud, Emanuelle, Rotem, Shahar, Steinberger-Levy, Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231171/ https://www.ncbi.nlm.nih.gov/pubmed/34208306 http://dx.doi.org/10.3390/microorganisms9061278 |
Ejemplares similares
-
Characterization of Yersinia pestis Phage Lytic Activity in Human Whole Blood for the Selection of Efficient Therapeutic Phages
por: Moses, Sarit, et al.
Publicado: (2021) -
A Rapid Antimicrobial Susceptibility Test for Determining Yersinia pestis Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers
por: Shifman, Ohad, et al.
Publicado: (2019) -
Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague
por: Vagima, Yaron, et al.
Publicado: (2022) -
Host Iron Nutritional Immunity Induced by a Live Yersinia pestis Vaccine Strain Is Associated with Immediate Protection against Plague
por: Zauberman, Ayelet, et al.
Publicado: (2017) -
Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures
por: Shifman, Ohad, et al.
Publicado: (2021)